A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 22, Issue 2, 2008, Pages 131-138

  Clark, Katherine ^a,b   Currow, David C ^c,f   Agar, Meera ^c,d   Fazekas, Belinda S ^c   Abernethy, Amy P ^c,e  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d Braeside Hospital   (Australia)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f Southern Adelaide Palliative Services   (Australia)

Author keywords

End of life care; Hyoscine hydrobromide; Octreotide; Palliative care; Secretions in the terminal phase

Indexed keywords

OCTREOTIDE; SCOPOLAMINE BROMIDE; GASTROINTESTINAL AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ADVANCED CANCER; AGED; ARTICLE; BREATHING DISORDER; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG CHOICE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NOISE; NURSING ASSESSMENT; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TERMINAL CARE; TREATMENT OUTCOME; ABNORMAL RESPIRATORY SOUND; COMPARATIVE STUDY; DRUG EFFECT; FAMILY; METHODOLOGY; MIDDLE AGED; NEOPLASM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT; RESPIRATORY SYSTEM; SECRETION; TERMINALLY ILL PATIENT;

AGED; AGED, 80 AND OVER; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FAMILY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NEOPLASMS; OCTREOTIDE; PALLIATIVE CARE; PILOT PROJECTS; RESPIRATORY SOUNDS; RESPIRATORY SYSTEM; SCOPOLAMINE; TERMINALLY ILL;

EID: 60549110691     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1080/15360280801992058     Document Type: Article

References (25)

1. Bennett M, Lucas V, Brennan M, Hughes A, O'Donnell V, Wee B. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliat Med. 2002;16(5):369-74.
2. Hughes AC, Wilcock A, Corcoran R. Management of "death rattle." J Pain Symptom Manage. 1996;12(5):271-2.
3. Bennett MI. Death rattle: an audit of hyoscine (scopolamine) use and review of management. J Pain Symptom Manage. 1996;12(4):229-33.
4. Power D, Kearney M. Management of the final 24 hours. Irish Med J. 1992;85(3):93-5.
5. Watts T, Jenkins K. Palliative care nurses' feelings about death rattle. J Clin Nurs. 1999;8(5):615-6.
6. Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage. 2002;23(4):310-7.
7. Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med. 2001;15(4):329-36.
8. Hughes A, Wilcock A, CorcoranR, Lucas V, King A. Audit of three antimuscarinic drugs for managing retained secretions. Palliat Med. 2000;14(3):221-2.
9. Reubi JC, Kvols L, Krenning E, Lamberts SWJ. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990;39(9) Suppl 2:78-81.
10. Lamberts SWJ, van Der Lely A-J, de Herder WW, Hofland LJ. Octreotide. N Engl J Med. 1996;334(4):246-53.
11. Dean A. The palliative effects of octreotide in cancer patients. Chemotherapy. 2001;47 Suppl 2:54-61.
12. Mercadante S. The role of octreotide in palliative care. J Pain Symptom Manage 1994;9(6):406-11.
13. Rees E, Hardy J. Novel consent process for research in dying patients unable to give consent. BMJ. 2003;327:198.
14. Jubb AM. Palliative care research: trading ethics for an evidence base. J Med Ethics. 2002;28(6):342-6.
15. Rees E. The ethics and practicalities of consent in palliative care research: an overview. International J Palliat Nurs. 2001;7(10):489-92.
16. Sachs GA. Advance consent for dementia research. Alzheimer Disease & Associated Disorders 1994; 8 Suppl 4:19-27.
17. Schmidt TA, Salo D, Hughes JA et al. Confronting the ethical challenges to informed consent in emergency medicine research. Academic Emerg Med. 2004;11(10):1082-9.
18. Marco CA, The Society for Academic Emergency Medicine position on informed consent for emergency medicine research. Academic Emerg Med. 2004;11(10):1090-1.
19. Alzheimers Association. Consensus recommendations: research consent for cognitively impaired adults. recommendations for institutional review boards and investigators. Alzheimer Disease & Associated Disorders. 2004;18(3):171-5.
20. Fost N. Can acutely ill patients consent to research? Resolving an ethical dilemma with facts. Academic Emerg Med. 1999;6(8):772-4.
21. Hardy J. Consent for trials in palliative care. Lancet. 2000;356 Suppl 1:S44.
22. Foëx BA. The problem of informed consent in emergency medicine research. Emerg M J. 2001;18(3):198-204.
23. Stuart-Harris R, Joel SP, McDonald P, Currow D, Slevin ML. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Brit J Clin Pharmacol.2000;49(3):207-14.
24. Wee BC, Coleman PG, Hillier R, Holgate SH. The sound of death rattle I: are relatives distressed by hearing this sound? Palliat Med. 2006;20(3):171-5.
25. Wee BC, Coleman PG, Hillier R, Holgate SH. The sound of death rattle II: How do relatives interpret the sound? Palliat Med. 2006;20(3):177-81.